Interaction between mevalonate pathway and retinoic acid-induced differentiation

Journal of Biomedicine and Biotechnology

Volumn 2001, Issue 3, 2001, Pages 108-113

  Gueddari Pouzols, Naima ^a   Duriez, Patrick ^b   Chomienne, Christine ^c   Trussardi, Aurélie ^a   Jardillier, Jean Claude ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COMPACTIN; GERANYLGERANYLTRANSFERASE INHIBITOR; GGTI 298; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENOID; MEVALONIC ACID; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RETINOIC ACID; STEROL; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; STATISTICAL SIGNIFICANCE;

EID: 33745271058     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/S1110724301000183     Document Type: Article

References (32)

1. Brockes J. Developmental biology. Reading the retinoid signals (news; comment). Nature. 1990;345:539-766.
2. Chomienne C, Ballerini P, Balitrand N, et al. All-transretinoic acid in acute promyelocytic leukemias II. In vitro studies: Structure-function relationship. Blood. 1990;76:1710-1717.
3. Razak K, Allen PD, Kelsey SM, Gutteridge CN, Newland AC. Modulation of CD13 expression during retinoic acid-induced differentiation of HL60 cells. Leuk Res. 1994;18:629-636.
4. Evans RM. The steroid and thyroid hormone receptor superfamily. Science. 1988;240:889-895.
5. Yang N, Schule R, Mangelsdorf DJ, Evans RM. Characterization of DNA binding and retinoic acid binding properties of retinoic acid receptor. Proc Natl Acad Sci USA. 1991;88:3559-3563.
6. Levin AA, Sturzenbecker LJ, Kazmer S, et al. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature. 1992;355:359-361.
7. Heyman RA, Mangelsdorf DJ, Dyck JA, et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 1992;68:397-406.
8. Breitman TR, Chen ZX, Takahashi N. Potential applications of cytodifferentiation therapy in hematologic malignancies. Semin Hematol. 1994;31:18-25.
9. Ruchaud S, Duprez E, Gendron MC, et al. Two distinctly regulated events, priming and triggering, during retinoid-induced maturation and resistance of NB4 promyelocytic leukemia cell line. Proc Natl Acad Sci USA. 1994;91:8428-8432.
10. Drach J, Lopez-Berestein G, McQueen TT, Andreeff M, Mehta K. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid. Cancer Res. 1993;53:2100-2104.
11. Goldstein JL, Brown MS. Regulation of mevalonate pathway. Nature. 1990;343:425-430.
12. Osborne TF, Gil G, Goldstein JL, Brown MS. Operator constitutive mutation of 3-hydroxy-3-methylglutaryl coenzyme A reductase promoter abolishes protein binding to sterol regulatory element. J Biol Chem. 1988;263:3380-3387.
13. Osborne TF. Single nucleotide resolution of sterol regulatory region in promoter for 3-hydroxy-3-methylglutaryl coenzyme A reductase. J Biol Chem. 1991;266:13947-13951.
14. Smith JR, Osborne TF, Brown MS, Goldstein JL. Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J Biol Chem. 1988;263:18480-18487.
15. Trzaskos JM, Magolda RM, Favata MF, et al. Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by 15 alpha-fluorolanost-7-en-3 beta-ol. A mechanismbased inhibitor of cholesterol biosynthesis. J Biol Chem. 1993;268:22591-22599.
16. Correll CC, Edwards PA. Mevalonic acid-dependent of 3-hydroxy-3- methylglutaryl-coenzyme A reductase in vivo and in vitro. J Biol Chem. 1994;269:633-638.
17. Correll CC, Ng L, Edwards PA. Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 1994;269:17390-17393.
18. Schafer WR, Kim R, Sterne R, Thorner J, Kim SH, Rine J. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans. Science. 1989;245:379-385.
19. Hancock JF, Magee AI, Childs JE, Marshall CJ. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell. 1989;57:1167-1177.
20. Glomset JA, Gelb MH, Farnsworth CC. Prenyl proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem Sci. 1990;15:139-142.
21. Casey PJ, Solsky PA, Der CJ, Buss JE. p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA. 1989;86:8323-8327.
22. Cox AD, Der CJ. The ras/cholesterol connection: implications for ras oncogenicity. Crit Rev Oncog. 1992;3:365-400.
23. Gibbs JB. Ras C-terminal processing enzymes-new drug targets?. Cell. 1991;65:1-4.
24. Prendergast GC, Davide JP, Desolms SJ, et al. Farnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton. Mol Cell Biol. 1994;14:4193-4202.
25. Glomset JA, Farnsworth CC. Role of protein modification reactions in programming interactions between ras-related GTPases and cell membranes. Annu Rev Cell Biol. 1994;10:181-205.
26. Casey PJ. Biochemistry of protein prenylation. J Lipid Res. 1992;33:1731-1740.
27. Grunler J, Ericsson J, Dallner G. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins. Biochim Biophys Acta. 1994;1212:259-277.
28. Marshall CJ. Protein prenylation: a mediator of protein-protein interactions. Science. 1993;259:1865-1866.
29. Tilbrook PA, Paterson HF, Marshall CJ. Reversion of a human tumour cell line containing oncogenic p21ras is associated with a defect in the post-translational processing of the ras protein. Oncogene. 1995;10:805-809.
30. Brousseau T, Clavey V, Bard JM, Fruchard JC. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles. Clin Chem. 1993;39:960-964.
31. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med. 1979;149:969-974.
32. Gueddari N, Bobichon H, Depierreux C, et al. Enhancement of All-Trans-Retinoic Acid Efficiency in granulocytic differentiation of HL-60 cells by incorporation into lowdensity lipoproteine. Int J Oncol. 1998;13:1069-1075.